Hosted on MSN1d
FDA Proposes Pulling Ineffective Decongestant From Market
An FDA advisory committee has unanimously concluded that oral phenylephrine, a decongestant found in many cold and flu ...
MedPage Today8h
Clozapine's REMS Program on the Chopping Block at Upcoming FDA Meeting
"Severe neutropenia occurs in a small percentage of patients taking clozapine; however, neutropenia is associated with an ...
FiercePharma3d
FDA rejects Intercept's ask for Ocaliva full nod in rare liver disease, but accelerated approval remains
In the wake of an unfavorable advisory committee meeting in September, Intercept Pharmaceuticals’ bid to win full approval ...
These Cold and Flu Medicines Contain Phenylephrine, the Ingredient the FDA Plans to Ban
Phenylephrine is a medication that’s been used to relieve nasal congestion caused by colds, allergies, and hay fever, per the ...
FDA moves to pull popular decongestant from shelves amid effectiveness concerns
The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular ...
JD Supra1d
FDA Advisory Committee outlines informed consent best practices
The U.S. Food and Drug Administration (FDA) recently held a Patient Engagement Advisory Committee meeting focused on clinical trial informed ...
ScienceAlert on MSN4d
FDA to Finally Ban Controversial Ingredient in Popular Decongestants
Sudafed, Mucinex, Benadryl, Advil, Tylenol, Vicks, and Dimetapp. These popular brand names appear on oral decongestants that ...
CCHR Int6h
CCHR Urges FDA Overhaul to End Psychiatric Drug and Device Harms
The Mental Health Watchdog calls for reforms to protect public safety, citing decades of antidepressant, electroshock, and psychedelic drug risks.
STAT11d
A Q&A with the FDA’s top vaccine regulator amid a fresh wave of disinformation
A fresh wave of disinformation about vaccines is flaring amid the 2024 campaign. The FDA's top vaccine official believes ...
FDA Wants To Pull Popular OTC Decongestant Used For Common Cold Over Effectiveness Concerns
On Thursday, the FDA proposed removing oral phenylephrine from the list of approved active ingredients for over-the-counter ...
FDA proposes removing ineffective decongestant found in most cold medicine
FDA officials said an agency review of the available data found oral phenylephrine is not effective as a nasal decongestant ...
RFK Jr. pick sparks FDA concerns
Robert F. Kennedy Jr.’s selection Thursday as President-elect Donald Trump’s Health and Human Services secretary nominee sent shockwaves through Washington.